Target intelligence / Profile preview

Pathogen antigens and toxins

Molecular classification
Protein, Polysaccharide, Lipid, Glycoprotein, Toxin
01

Overview

Pathogen antigens and toxins represent a diverse group of molecules derived from infectious agents, including bacteria, viruses, fungi, and parasites, that elicit an immune response or cause direct damage to host tissues (NIH, 2022). Antigens are typically surface-exposed proteins or polysaccharides that serve as the primary targets for vaccines and therapeutic antibodies, facilitating pathogen recognition and clearance by the immune system (CDC, 2023). Toxins are specialized virulence factors, such as exotoxins or endotoxins, that disrupt host cellular processes, often leading to severe clinical manifestations like sepsis or organ failure (StatPearls, 2023). In drug development, these molecules are targeted to prevent infection through prophylaxis or to neutralize harmful effects during an active disease state using monoclonal antibodies like bezlotoxumab or raxibacumab (FDA, 2023). Because this category encompasses a vast array of structurally distinct molecules, therapeutic strategies vary widely, ranging from small molecule inhibitors of toxin activity to complex biologicals that mimic or enhance the host's natural defenses (PubMed, 2021). Monitoring these targets often involves measuring antigen or toxin levels in blood or tissue to guide treatment efficacy and patient selection (WHO, 2022).

Other names
Microbial antigensVirulence factorsExotoxinsEndotoxinsPathogen-associated molecular patternsPAMPsInfectious agent antigens
02

Mechanism of action

Neutralization of biological activity, inhibition of host cell binding, and induction of adaptive immune responses.

03

Biological functions

Immune responsePathogenesisCell deathHost cell entryEnzymatic activity
04

Disease associations

InfectionSepsisToxemiaInflammation
05

Safety considerations

AnaphylaxisCytokine release syndromeAntibody-dependent enhancementOff-target cross-reactivityAntigenic drift
06

Interacting drugs

Bezlotoxumab

6 more in the full profile.

07

Biomarkers

Serum antigen levelsAntibody titersToxin assaysPathogen load

Beyond the preview

Go deeper on Pathogen antigens and toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen antigens and toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call